Skip to main content
SpringerLink
Log in

Universal HIV testing and treatment cost effective in Zambia and SA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2017 US dollars

Reference

  • Thomas R, et al. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. The Lancet Global Health : 12 Mar 2021. Available from: URL: https://doi.org/10.1016/S2214-109X(21)00034-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Universal HIV testing and treatment cost effective in Zambia and SA. PharmacoEcon Outcomes News 875, 33 (2021). https://doi.org/10.1007/s40274-021-7612-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7612-4

Search

Navigation